Hidden Hormone Chaos: How Insulin Resistance May Drive Far More Than Syndrome X

Table of Contents

• Key Points
• Why This Research Matters
• Understanding Insulin Resistance and Compensatory Hyperinsulinemia
• How High-Glycemic Foods Trigger the Problem
• The Surprising Role of Fructose
• The Century-Long Rise of Sugar in Our Diets
• What About Dietary Fat?
• Growth Factors: How High Insulin Levels Affect Cell Growth
• The Retinoid Connection: A Missing Link
• Expanding the Definition of Syndrome X
• What This Means for Patients
• Study Limitations
• Practical Recommendations for Patients
• Frequently Asked Questions
• Source Information

Key Points

• Compensatory hyperinsulinemia is the body producing extra insulin to overcome insulin resistance, and it may underlie many 'diseases of civilization.'
• High-glycemic-load carbohydrates uniquely promote all four dietary causes of insulin resistance, including elevated glucose, insulin, VLDL, and free fatty acids.
• Fructose, especially as high-fructose corn syrup, can induce insulin resistance and raise blood fats even at moderate intake, despite a low glycemic index.
• Isocaloric high-fat diets do not cause insulin resistance; harm arises when high-fat foods are combined with refined carbs and excess calories.
• Expanded Syndrome X includes acne, early puberty, myopia, skin tags, PCOS, baldness, certain cancers, and increased height, linked to insulin's effects on growth hormones.

Why This Research Matters

Almost 60 years have passed since clinicians and researchers first suspected that tissue resistance to insulin—the hormone that helps your body use sugar for energy—might play a role in chronic diseases. In the past decade or so, scientists came to recognize a unifying concept: insulin resistance and its metabolic consequence, compensatory hyperinsulinemia (the body pumping out extra insulin to compensate for the resistance), link together a cluster of conditions including type 2 diabetes, coronary artery disease, high blood pressure, obesity, abnormal glucose tolerance, and dyslipidemia (abnormal blood fats). This cluster is frequently called the metabolic syndrome or Syndrome X. Abnormalities of fibrinolysis (the body's ability to dissolve blood clots) and hyperuricemia (elevated uric acid) also appear to belong to this group.

The scale of the problem is enormous. In the United States, 63% of men and 55% of women over age 25 are either overweight or obese, and an estimated 280,184 deaths per year are attributable to obesity. More than 60 million Americans have one or more types of cardiovascular disease, which is the leading cause of death, accounting for 40.6% of all deaths in the US. Approximately 50 million Americans have high blood pressure, 10 million have type 2 diabetes, and 72 million adults maintain total cholesterol-to-HDL (high-density lipoprotein, or "good" cholesterol) ratios of 4.5 or greater—a marker of increased heart risk.

Astonishingly, these diseases are either rare or virtually non-existent in hunter-gatherer societies and other less westernized peoples who live and eat in their traditional manner. This is why Syndrome X diseases have been dubbed the "Diseases of Civilization" by numerous authors. The paper argues that this web of diseases extends far beyond the usual suspects—and that dietary changes over the past two centuries are largely responsible.

Understanding Insulin Resistance and Compensatory Hyperinsulinemia

When you eat carbohydrates, enzymes in your digestive tract break them down into glucose, which is rapidly absorbed into your bloodstream. Within the first 2 hours after eating, blood sugar levels rise. This elevated blood glucose, along with gut hormones called glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1, stimulates the pancreas to release insulin. The size of this blood sugar and insulin spike depends primarily on two related measures: the glycemic index (GI), which ranks how quickly a food raises blood sugar compared to pure glucose, and the glycemic load (GL), which is calculated as GI multiplied by the carbohydrate content per serving size.

Eating mixed meals that contain protein and fat along with carbohydrates can lower the total glycemic and insulin response. However, research clearly shows that repeated consumption of high-glycemic-index mixed meals results in higher average 24-hour blood glucose and insulin concentrations compared to low-glycemic-index mixed meals with the same calorie content.

When skeletal muscle resists insulin's signal to take up glucose, clinicians call this insulin resistance. While skeletal muscle is the main site of insulin-stimulated glucose uptake, adipose tissue (body fat), the liver, and endothelial cells (the lining of blood vessels) can also develop insulin resistance. The molecular basis is complex, but the paper identifies four dietary-related proximate causes:

1. Chronic and substantial elevations of blood glucose
2. Elevated insulin levels themselves
3. Very low-density lipoproteins (VLDL, a type of "bad" fat particle produced by the liver)
4. Free fatty acids (fat molecules released from fat tissue)

Initially, blood glucose doesn't necessarily rise to dangerous levels when tissues become insulin resistant, because the pancreas simply secretes more insulin to force glucose into cells. This maintains normal blood sugar through elevated insulin—a state called compensatory hyperinsulinemia. This is the fundamental metabolic disturbance underlying Syndrome X. However, if the pancreas eventually fails to keep up, impaired glucose tolerance or full-blown type 2 diabetes develops.

How High-Glycemic Foods Trigger the Problem

Of the four proximate dietary causes of insulin resistance, consumption of high-glycemic-load carbohydrates has the unique potential to promote all four. In the early post-meal period (1–2 hours), blood glucose levels are significantly higher after high-glycemic-index meals. Plasma insulin concentrations are also higher during this period. In the late post-meal period (4–6 hours), high-glycemic-load meals cause a rebound increase in non-esterified free fatty acids in the blood, driven by enhanced breakdown (lipolysis) of fat stored in adipose tissue. High-glycemic-load meals also cause increased secretion of VLDL particles by the liver.

Furthermore, insulin itself becomes stimulatory for VLDL secretion in the post-meal state when the time between meals is short and insulin levels never fall back to baseline. Taken together, these hormonal and metabolic changes—especially when combined with excess calorie intake—promote the development of insulin resistance and compensatory hyperinsulinemia over a 24-hour period.

The following examples from the original paper illustrate the contrast between typical Western refined foods and unrefined traditional foods (measured per 100-gram portion, with glucose as the reference GI of 100):

Western refined foods (GI / GL):

• Pure glucose: GI 97, GL 96.8
• Rice Krispies cereal: GI 88, GL 77.3
• Cornflakes: GI 84, GL 72.7
• Life Savers candy: GI 70, GL 67.9
• Rice cakes: GI 82, GL 66.9
• Table sugar (sucrose): GI 65, GL 64.9
• Graham crackers: GI 74, GL 56.8
• White bread: GI 70, GL 34.7
• Doughnuts: GI 76, GL 37.8
• Bagel: GI 72, GL 38.4

Unrefined traditional foods (GI / GL):

• Boiled broad beans: GI 79, GL 15.5
• Boiled sweet potato: GI 54, GL 13.1
• Banana: GI 53, GL 12.1
• Carrots: GI 71, GL 7.2 (high GI but very low GL because of low carbohydrate content)
• Apple: GI 39, GL 6.0
• Boiled lentils: GI 29, GL 5.8
• Boiled kidney beans: GI 27, GL 6.2
• Cherries: GI 22, GL 3.7
• Peanuts: GI 14, GL 2.6

The Surprising Role of Fructose

Fructose—the naturally occurring sugar found in fruit—has a low glycemic index and load, but paradoxically, it may be a major contributor to insulin resistance. Researchers routinely use high-fructose diets to induce insulin resistance in laboratory rats (at 35–65% of energy intake) and hamsters. In healthy humans, consuming an additional 1,000 kilocalories of fructose per day on top of a usual diet impairs insulin sensitivity. Even lower concentrations (20% of energy from fructose) worsened insulin sensitivity in men with hyperinsulinemia. More recent work showed that fructose infusions in healthy normal men and women induce both hepatic (liver) and extrahepatic (outside the liver) insulin resistance.

Although pure (100%) crystalline fructose elicits only a minimal insulin response when eaten alone, it becomes strikingly insulin-stimulating when blood glucose levels are even moderately elevated. The main sources of fructose in the US diet are high-fructose corn syrup (HFCS) 42 and HFCS 55—liquid mixtures of fructose and glucose (42% fructose/53% glucose and 55% fructose/42% glucose, respectively). Because these manufactured forms combine fructose with glucose, they trigger both high glycemic and high insulin responses, similar to honey (which is 42% fructose and 34% glucose).

Fructose has also been shown to elevate serum triglycerides (blood fats) and VLDL concentrations, even at levels achievable in a normal diet (17% of energy) in healthy subjects. Among all sugars, fructose is unique in shifting the balance of free fatty acids from oxidation (burning for energy) to esterification (storing as fat) in the liver, which contributes to both liver and whole-body insulin resistance.

The Century-Long Rise of Sugar in Our Diets

Refined sugars and cereals were eaten sparingly—or not at all—by the average citizen in 17th- and 18th-century Europe. They only became widely available in large quantities after the Industrial Revolution. In England, per capita sucrose consumption increased steadily from 6.8 kg per year in 1815 to 54.5 kg per year in 1970—an eightfold increase. Similar trends occurred in the US and most European countries.

Upon digestion, sucrose is broken down in the gut into equal molecular parts of glucose and fructose. So the historical surge in sucrose consumption translated into a massive increase in both glucose and fructose intake. In 1960, sucrose was the dominant sweetener in the US diet, accounting for about 90% of all sugars in the food supply. The rest was corn sweeteners containing only glucose. But with the invention of chromatographic fructose enrichment technology in the late 1970s, mass production of high-fructose corn syrup became economically feasible—and the American diet changed forever.

US Department of Agriculture data show dramatic shifts in sweetener consumption from 1970 to 2000 (pounds per person per year):

• Refined sucrose: declined from 46.2 kg to 29.8 kg
• HFCS 42: rose from 0.2 kg to 11.2 kg
• HFCS 55: rose from 0 to 17.7 kg
• Unbound refined fructose: rose from just 0.3 kg to 14.7 kg—an astounding 4,800% increase in 30 years
• Total fructose (unbound plus fructose from sucrose breakdown): increased 26%, from 23.4 kg to 29.6 kg
• Total sugars: increased from 55.5 kg to 69.1 kg

Per capita sugar consumption in the US increased by 64% from 1909 to 1999, while fiber intake declined by 17.9% during the same period. Total carbohydrate intake remained fairly constant until a roughly 10% rise in the 1990s. But the quality of carbohydrates changed dramatically. High-glycemic-load refined cereal products now make up 85.3% of all grain products consumed in the US. In 1999, grain products supplied 23.7% of total per capita energy, meaning refined high-glycemic grain products alone supply about 20% of the energy in the typical American diet. This became possible only with the introduction of steel roller mills in the late 19th century (around 1880), which produced fiber-depleted wheat flour of low extraction.

Adding it all up: high-glycemic-load sugars (HFCS 42, HFCS 55, sucrose, glucose, honey, and syrups) now supply 16.1% of total energy, and high-glycemic-load refined cereal grains supply about 20% of energy. That means at least 36% of the total energy in the typical US diet comes from foods known to promote all four proximate causes of insulin resistance. These foods were rarely or never consumed as recently as 200 years ago—making the modern human diet a radical experiment in metabolic stress.

What About Dietary Fat?

Per capita dietary fat increased by 32% from 1909–1919 to 1990–1999, while total energy intake increased by 9%. The increase in fat came primarily from monounsaturated and polyunsaturated fats; saturated fat consumption remained nearly constant over the past 90 years. So the increased consumption of dietary fat parallels that of dietary sugar.

However, fat alone—under conditions of equal calorie intake (isocaloric conditions)—does not cause insulin resistance in humans. A landmark human experiment using the "gold standard" hyperinsulinemic euglycemic clamp technique found that a range of isocaloric diets containing up to 83% fat did not directly cause insulin resistance. The 83% fat diet actually improved certain aspects of glucose homeostasis. Only under hypercaloric conditions (eating more calories than you burn), when increased dietary fat leads to obesity, does insulin resistance result.

Yet there's an important catch. Many high-glycemic-index foods are also high-fat foods—think doughnuts (49% fat, GI 76), corn chips (56% fat, GI 72), Mars bars (45% fat, GI 68), vanilla wafers (42% fat, GI 77), croissants (47% fat, GI 67), and cheese pizza (36% fat, GI 60). High-glycemic-load carbohydrates frequently initiate a destructive cycle: insulin-induced hypoglycemia (low blood sugar) followed by hyperphagia (intense hunger and overeating), in which more high-glycemic-index carbohydrates are preferentially consumed. The energy-dense fat in these foods is thus consumed simultaneously with the refined sugars and starches that promote insulin resistance.

Growth Factors: How High Insulin Levels Affect Cell Growth

The metabolic consequences of chronic hyperinsulinemia go far beyond blood sugar control. Insulin is a well-established growth-promoting hormone, and emerging evidence shows that high insulin levels shift multiple endocrine pathways in ways that may favor unregulated tissue growth.

Insulin-like growth factor-1 (IGF-1) is a potent growth factor for virtually all of the body's tissues. In the bloodstream, most IGF-1 is bound to proteins called IGF-binding proteins, which control how much "free" (biologically active) IGF-1 is available. The most important of these is IGFBP-1. Chronic hyperinsulinemia—such as that seen in adolescent obesity—chronically suppresses the liver's production of IGFBP-1, which in turn increases free IGF-1 levels.

Insulin and IGFBP-1 levels vary inversely throughout the day: when insulin is high, IGFBP-1 falls, and free IGF-1 rises. This suppression is maximal when insulin levels exceed 70–90 picomoles per liter (pmol/L)—a level easily reached after typical high-carbohydrate meals. In addition, elevated free IGF-1 feeds back to reduce growth hormone secretion, which in turn lowers levels of IGFBP-3 (another binding protein). Both acute and chronic elevations of insulin therefore result in increased free IGF-1 and reduced IGFBP-3 levels.

This matters because IGFBP-3 is not just a passive carrier protein. It acts as a growth inhibitory factor in its own right, even in cells lacking the IGF-1 receptor. When IGFBP-3 levels fall, cells lose an important brake on proliferation. Because consumption of refined sugars and starches promotes both acute and chronic hyperinsulinemia, these common foods have the potential to elevate free IGF-1 and lower IGFBP-3, thereby stimulating growth in a wide variety of tissues throughout the body.

The Retinoid Connection: A Missing Link

Insulin-mediated reductions in IGFBP-3 may promote unregulated tissue growth through yet another pathway: the body's retinoid signaling system. Retinoids are natural and synthetic analogs of vitamin A that inhibit cell proliferation and promote apoptosis (programmed cell death). The body's natural retinoids—trans-retinoic acid and 9-cis-retinoic acid—work by binding to two families of nuclear receptors: retinoic acid receptors (RARs) and retinoid X receptors (RXRs). These receptors activate gene transcription by pairing up as RAR/RXR heterodimers or RXR/RXR homodimers, attaching to specific DNA response elements in the promoter regions of target genes. The function of these genes is to limit growth in many cell types.

Here's where the connection gets interesting: IGFBP-3 itself is a ligand (a binding molecule) for the RXR alpha receptor, and it enhances RXR/RXR homodimer-mediated signaling. Studies in knockout rodents show that the RXR alpha gene is required for the actions of both endogenous retinoic acid ligands. Both RXR alpha agonists and IGFBP-3 are growth-inhibitory in many cell lines. Importantly, RXR alpha is the major RXR receptor in epithelial tissue—the tissue that lines surfaces throughout the body, from skin to internal organs.

Consequently, when hyperinsulinemia drives down plasma IGFBP-3 levels, the body loses a key activator of the retinoid signaling pathway. This may reduce the transcription of anti-proliferative genes that are normally switched on by endogenous retinoids—removing a critical safety brake on cell growth. This mechanism may help explain why conditions involving unregulated tissue growth (such as epithelial cancers, skin tags, and acanthosis nigricans) are associated with insulin resistance.

Expanding the Definition of Syndrome X

The paper synthesizes these hormonal shifts into a unifying model. Hyperinsulinemia elevates serum concentrations of free IGF-1 and androgens (male-type hormones), while simultaneously reducing IGFBP-3 and sex hormone-binding globulin (SHBG)—the protein that normally binds and inactivates androgens in the blood. When SHBG is low, more androgen is free and active. The original paper text is truncated at this point in the version provided, but the abstract clearly establishes the full list of conditions believed to result from these endocrine shifts:

• Acne—driven by androgen and IGF-1 effects on sebaceous glands
• Early menarche (earlier onset of puberty in girls)
• Certain epithelial cell carcinomas—notably breast, colon, and prostate cancers
• Increased stature (the secular trend toward taller adult height)
• Myopia (nearsightedness)
• Cutaneous papillomas (skin tags)
• Acanthosis nigricans (darkened, thickened patches of skin, often on the neck or armpits)
• Polycystic ovary syndrome (PCOS)—a hormonal disorder affecting women of reproductive age
• Male vertex balding (male-pattern hair loss)

Because these conditions are driven, at least in part, by insulin-altered hormonal pathways, the authors argue they should be classified among the diseases of Syndrome X. The model is illustrated as a cascade: insulin resistance → compensatory hyperinsulinemia → elevated free IGF-1 and androgens, reduced IGFBP-3 and SHBG → enhanced and unregulated tissue growth in multiple tissues → the diverse clinical conditions listed above.

What This Means for Patients

For patients, this research carries a powerful message: the type of carbohydrate you eat matters enormously, not just for weight and blood sugar, but for hormonal balance and tissue health throughout the body. The standard American diet, in which more than a third of all calories come from high-glycemic-load sugars and refined grains, keeps insulin levels chronically elevated. Over months and years, this drives a hormonal environment that promotes growth and inflammation in tissues as different as skin, hair follicles, ovaries, eyes, and the lining of the colon.

The paper also has implications for how doctors think about patients who present with seemingly unrelated complaints. A teenager with acne, a woman with PCOS and skin tags, a man with early vertex balding, and a patient with a family history of prostate or breast cancer may all share a common underlying metabolic driver: hyperinsulinemia. Recognizing these conditions as part of the Syndrome X family opens the door to dietary interventions that address the root cause rather than just treating each symptom in isolation.

Study Limitations

It is important to understand what this paper can and cannot prove. It is a hypothesis/review paper, not a clinical trial. The evidence it draws on includes epidemiological trends, mechanistic studies, and animal experiments, but it does not itself test interventions in patients. The link between hyperinsulinemia and conditions like myopia or increased stature is plausible and biologically grounded, but direct human intervention trials demonstrating that lowering insulin levels reverses or prevents these conditions are not yet available. The secular trend data (e.g., rising sugar consumption over 200 years) are correlational and can be influenced by many confounding factors. Genetic susceptibility also plays a role; not everyone who eats a high-glycemic-load diet develops insulin resistance or these associated conditions.

Practical Recommendations for Patients

Based on the evidence presented in this paper, patients can take several actionable steps:

1. Choose low-glycemic-load carbohydrates. Favor foods like lentils, kidney beans, apples, pears, peaches, cherries, and peanuts, which have glycemic loads below 10 per serving, over refined foods like cornflakes, rice cakes, white bread, and doughnuts, which can have glycemic loads of 35–97.
2. Beware of high glycemic index foods that are actually fine to eat. Carrots have a high GI (71) but a very low glycemic load (7.2) because they contain relatively little carbohydrate. Glycemic load matters more than glycemic index alone.
3. Limit high-fructose corn syrup and processed foods sweetened with HFCS 42 or HFCS 55. Unbound fructose consumption in the US increased 4,800% between 1970 and 2000, and even moderate amounts (17% of energy) can raise blood fats and worsen insulin sensitivity.
4. Increase fiber intake. Average fiber consumption declined by 17.9% over the 20th century. Whole, unprocessed plant foods are the best sources.
5. Understand that fat alone is not the enemy. The research shows that isocaloric diets containing up to 83% fat did not cause insulin resistance. The problem arises when high-fat foods are combined with high-glycemic refined carbohydrates (doughnuts, pizza, chips) and when total calorie intake is excessive.
6. Break the hypoglycemia-hyperphagia cycle. High-glycemic meals cause blood sugar spikes followed by crashes, which trigger intense hunger and cravings for more high-glycemic foods. Choosing lower-glycemic meals helps stabilize blood sugar and appetite.
7. If you have a condition on the expanded Syndrome X list—acne, PCOS, skin tags, acanthosis nigricans, or early balding—talk to your doctor about checking insulin resistance markers, not just fasting blood sugar. Conditions like acanthosis nigricans and skin tags are visible signs that may indicate metabolic problems worth addressing.

Frequently Asked Questions

What is compensatory hyperinsulinemia?

When tissues resist insulin's signal, the pancreas secretes extra insulin to force glucose into cells, keeping blood sugar normal. This elevated insulin state is called compensatory hyperinsulinemia. It is the fundamental metabolic disturbance underlying Syndrome X and may drive many health problems beyond obesity, diabetes, and heart disease.

Which common conditions may be linked to insulin resistance beyond the classic Syndrome X cluster?

The expanded list includes acne, early puberty in girls, myopia (nearsightedness), skin tags, acanthosis nigricans, polycystic ovary syndrome, male-pattern baldness, certain cancers (breast, colon, prostate), and increased adult height. These are thought to result from high insulin altering growth-related hormones.

How does eating high-glycemic foods affect insulin and health?

High-glycemic foods cause rapid blood sugar and insulin spikes, followed by a rebound in free fatty acids and increased VLDL. Over time, this promotes insulin resistance and compensatory hyperinsulinemia. Repeated consumption of such meals keeps insulin elevated throughout the day, potentially stimulating tissue growth and contributing to various conditions.

Is fructose harmful even if it has a low glycemic index?

Yes. Although pure fructose has a low glycemic index, high-fructose corn syrup combines fructose with glucose, producing high responses. Fructose can cause insulin resistance and raise blood fats even at moderate intakes. It also shifts the liver toward fat storage, worsening insulin resistance.

Does dietary fat cause insulin resistance?

No, under equal calorie conditions, fat alone does not cause insulin resistance. In one gold-standard study, diets with up to 83% fat did not directly cause insulin resistance; only overeating and resulting obesity did. However, many high-fat processed foods also contain high-glycemic carbs, which together are harmful.

What practical diet changes can help reduce insulin resistance?

Choose low-glycemic-load carbohydrates like lentils, beans, apples, and cherries, and beware that carrots have a high glycemic index but low load. Limit high-fructose corn syrup and processed foods, increase fiber intake, and remember that fat alone is not the enemy. Stabilizing blood sugar helps control appetite.

What are the limitations of this research linking insulin resistance to many conditions?

This is a hypothesis/review paper, not a clinical trial. The evidence includes epidemiological trends and animal studies, but direct human trials showing that lowering insulin reverses conditions like myopia or stature are lacking. Secular trends are correlational, and genetic susceptibility means not everyone eating high-glycemic diets develops insulin resistance.

Should I get a second opinion about whether my PCOS, skin tags, or acne are caused by insulin resistance?

Insulin resistance and the body's compensatory rise in insulin may contribute to acne, PCOS, skin tags, male-pattern baldness, and certain cancers, according to the expanded metabolic syndrome model. The evidence for these links is largely mechanistic and observational, not from clinical trials. If you have one of these conditions, a second opinion can help determine whether checking insulin resistance markers or trying dietary changes to lower insulin is worthwhile for you. Diagnostic Detectives Network provides independent expert second opinions.

Source Information

Original article title: Comparative Biochemistry and Physiology Part A 136 (2003) 95–112

Authors: Loren Cordain, Michael R. Eades, Mary D. Eades

Journal: Comparative Biochemistry and Physiology Part A 136 (2003) 95–112

Note: This patient-friendly article is based on peer-reviewed research. This paper is part of a collection of interdisciplinary, peer-reviewed articles under the theme: "Origin and Diversity of Human Physiological Adaptability." The original text was truncated in the version provided, so some content beyond the abstract's condition list (e.g., detailed discussion of individual conditions) was not available for this translation.